Jingye Zhou
Company: Eccogene
Job title: Co-Founder & Chief Executive Officer
Seminars:
Panel Discussion: Navigating the Evolving NASH Landscape to Apprehend the Future of Combination Therapies & Optimize Treatment 2:30 pm
Deliberating the best approaches to position GLP-1s for different indications, mono therapy, and combination therapy How are we maximizing the use of injectables and oral medicines? Uniting towards a shared goal to advances towards efficacious NASH treatments through collaborative effortsRead more
day: Day 1 Seminar B Post-Lunch Tracks